Trial Outcomes & Findings for A Behavioral Intervention To Improve Hypertension Control In Veterans (NCT NCT00286754)

NCT ID: NCT00286754

Last Updated: 2015-06-01

Results Overview

Blood pressure Control at 6 months

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

533 participants

Primary outcome timeframe

6 months

Results posted on

2015-06-01

Participant Flow

Participant milestones

Participant milestones
Measure
Stage-matched Intervention (SM)
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
6 monthly phone calls of non-tailored counseling for diet, medication and exercise
Usual Care (UC)
treatment as usual with no additional counseling
Overall Study
STARTED
176
177
180
Overall Study
COMPLETED
156
159
170
Overall Study
NOT COMPLETED
20
18
10

Reasons for withdrawal

Reasons for withdrawal
Measure
Stage-matched Intervention (SM)
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
6 monthly phone calls of non-tailored counseling for diet, medication and exercise
Usual Care (UC)
treatment as usual with no additional counseling
Overall Study
Adverse Event
2
2
3
Overall Study
Withdrawal by Subject
6
2
0
Overall Study
Lost to Follow-up
12
14
6
Overall Study
Moved out of state
0
0
1

Baseline Characteristics

A Behavioral Intervention To Improve Hypertension Control In Veterans

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Stage-Matched Intervention (SMI)
n=176 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=177 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=180 Participants
treatment as usual for hypertension
Total
n=533 Participants
Total of all reporting groups
History of revascularization
History of revascularization
27 participants
n=99 Participants
28 participants
n=107 Participants
31 participants
n=206 Participants
86 participants
n=157 Participants
History of revascularization
No history of revascularization
149 participants
n=99 Participants
149 participants
n=107 Participants
149 participants
n=206 Participants
447 participants
n=157 Participants
Hyperlipidemia
Hyperlipidemia
39 participants
n=99 Participants
38 participants
n=107 Participants
52 participants
n=206 Participants
129 participants
n=157 Participants
Age, Continuous
Age and Standard Deviation
66.4 years
STANDARD_DEVIATION 8.8 • n=99 Participants
66.5 years
STANDARD_DEVIATION 12.8 • n=107 Participants
65.4 years
STANDARD_DEVIATION 10.2 • n=206 Participants
66.1 years
STANDARD_DEVIATION 18.5 • n=157 Participants
Sex: Female, Male
Female
2 Participants
n=99 Participants
1 Participants
n=107 Participants
4 Participants
n=206 Participants
7 Participants
n=157 Participants
Sex: Female, Male
Male
174 Participants
n=99 Participants
176 Participants
n=107 Participants
176 Participants
n=206 Participants
526 Participants
n=157 Participants
Race/Ethnicity, Customized
White (non-Hispanic)
81 participants
n=99 Participants
60 participants
n=107 Participants
71 participants
n=206 Participants
212 participants
n=157 Participants
Race/Ethnicity, Customized
Black (non-Hispanic)
65 participants
n=99 Participants
77 participants
n=107 Participants
70 participants
n=206 Participants
212 participants
n=157 Participants
Race/Ethnicity, Customized
Hispanic
24 participants
n=99 Participants
29 participants
n=107 Participants
29 participants
n=206 Participants
82 participants
n=157 Participants
Race/Ethnicity, Customized
Other
6 participants
n=99 Participants
11 participants
n=107 Participants
10 participants
n=206 Participants
27 participants
n=157 Participants
Marital status
Married
59 participants
n=99 Participants
67 participants
n=107 Participants
70 participants
n=206 Participants
196 participants
n=157 Participants
Hyperlipidemia
No hyperlipidemia
137 participants
n=99 Participants
139 participants
n=107 Participants
128 participants
n=206 Participants
404 participants
n=157 Participants
Marital status
Not Married
117 participants
n=99 Participants
110 participants
n=107 Participants
110 participants
n=206 Participants
337 participants
n=157 Participants
Education
High school graduate or below
72 participants
n=99 Participants
89 participants
n=107 Participants
87 participants
n=206 Participants
248 participants
n=157 Participants
Education
Some college or higher
104 participants
n=99 Participants
88 participants
n=107 Participants
93 participants
n=206 Participants
285 participants
n=157 Participants
Employment status
Employed
29 participants
n=99 Participants
41 participants
n=107 Participants
41 participants
n=206 Participants
111 participants
n=157 Participants
Employment status
Not employed
147 participants
n=99 Participants
136 participants
n=107 Participants
139 participants
n=206 Participants
422 participants
n=157 Participants
Campus
Manhattan campus
96 participants
n=99 Participants
96 participants
n=107 Participants
97 participants
n=206 Participants
289 participants
n=157 Participants
Campus
Brooklyn campus
80 participants
n=99 Participants
81 participants
n=107 Participants
83 participants
n=206 Participants
244 participants
n=157 Participants
Smoking
Current smoker
35 participants
n=99 Participants
32 participants
n=107 Participants
32 participants
n=206 Participants
99 participants
n=157 Participants
Smoking
Current non-smoker
141 participants
n=99 Participants
145 participants
n=107 Participants
148 participants
n=206 Participants
434 participants
n=157 Participants
Body mass index
30.5 kg/m^2
STANDARD_DEVIATION 5.2 • n=99 Participants
31.2 kg/m^2
STANDARD_DEVIATION 5.8 • n=107 Participants
30.0 kg/m^2
STANDARD_DEVIATION 4.8 • n=206 Participants
30.5 kg/m^2
STANDARD_DEVIATION 5.3 • n=157 Participants
Blood pressure control
BP controlled
75 participants
n=99 Participants
72 participants
n=107 Participants
80 participants
n=206 Participants
227 participants
n=157 Participants
Blood pressure control
BP not controlled
101 participants
n=99 Participants
105 participants
n=107 Participants
100 participants
n=206 Participants
306 participants
n=157 Participants
Diabetes Mellitus
Diabetes mellitus
71 participants
n=99 Participants
83 participants
n=107 Participants
81 participants
n=206 Participants
235 participants
n=157 Participants
Diabetes Mellitus
No diabetes mellitus
105 participants
n=99 Participants
94 participants
n=107 Participants
99 participants
n=206 Participants
298 participants
n=157 Participants
Ischemic Heart Disease (IHD)
History of IHD
23 participants
n=99 Participants
22 participants
n=107 Participants
23 participants
n=206 Participants
68 participants
n=157 Participants
Ischemic Heart Disease (IHD)
No history of IHD
153 participants
n=99 Participants
155 participants
n=107 Participants
157 participants
n=206 Participants
465 participants
n=157 Participants
Estimated glomerular filtration rate (EGFR)
79.9 mL/min/1.73m^2
STANDARD_DEVIATION 25.5 • n=99 Participants
83.2 mL/min/1.73m^2
STANDARD_DEVIATION 46.3 • n=107 Participants
80.6 mL/min/1.73m^2
STANDARD_DEVIATION 28.4 • n=206 Participants
81.3 mL/min/1.73m^2
STANDARD_DEVIATION 35.8 • n=157 Participants
Systolic Blood Pressure, mm Mg
136.0 mm Hg
STANDARD_DEVIATION 11.8 • n=99 Participants
137.2 mm Hg
STANDARD_DEVIATION 17.7 • n=107 Participants
137.0 mm Hg
STANDARD_DEVIATION 12.9 • n=206 Participants
136.7 mm Hg
STANDARD_DEVIATION 15.5 • n=157 Participants
Diastolic blood pressure
75.5 mm Hg
STANDARD_DEVIATION 9.3 • n=99 Participants
76.1 mm Hg
STANDARD_DEVIATION 11.6 • n=107 Participants
75.0 mm Hg
STANDARD_DEVIATION 11.1 • n=206 Participants
75.5 mm Hg
STANDARD_DEVIATION 11.6 • n=157 Participants
Aerobic exercise
5.3 hours per week
STANDARD_DEVIATION 8.1 • n=99 Participants
4.5 hours per week
STANDARD_DEVIATION 5.9 • n=107 Participants
5.0 hours per week
STANDARD_DEVIATION 6.7 • n=206 Participants
4.9 hours per week
STANDARD_DEVIATION 6.7 • n=157 Participants
Medication adherence by Morisky scale
3.4 units on a scale
STANDARD_DEVIATION 0.93 • n=99 Participants
3.2 units on a scale
STANDARD_DEVIATION 0.67 • n=107 Participants
3.3 units on a scale
STANDARD_DEVIATION 0.94 • n=206 Participants
3.3 units on a scale
STANDARD_DEVIATION 0.88 • n=157 Participants
Number of antihypertensive medications
2.7 medications
STANDARD_DEVIATION 1.5 • n=99 Participants
2.8 medications
STANDARD_DEVIATION 1.3 • n=107 Participants
2.7 medications
STANDARD_DEVIATION 1.3 • n=206 Participants
2.7 medications
STANDARD_DEVIATION 1.4 • n=157 Participants
Diet stage of change
Action or Maintenance
69 participants
n=99 Participants
67 participants
n=107 Participants
70 participants
n=206 Participants
206 participants
n=157 Participants
Diet stage of change
Precontemplation, Contemplation or Preparation
107 participants
n=99 Participants
110 participants
n=107 Participants
110 participants
n=206 Participants
327 participants
n=157 Participants
Exercise Stage of Change
Action or Maintenance
125 participants
n=99 Participants
110 participants
n=107 Participants
108 participants
n=206 Participants
343 participants
n=157 Participants
Exercise Stage of Change
Precontemplation, Contemplation, or Preparation
51 participants
n=99 Participants
67 participants
n=107 Participants
72 participants
n=206 Participants
190 participants
n=157 Participants
Medication Stage of Change
Action or Maintenance
164 participants
n=99 Participants
170 participants
n=107 Participants
166 participants
n=206 Participants
500 participants
n=157 Participants
Medication Stage of Change
Precontemplation, Contemplation or Preparation
12 participants
n=99 Participants
7 participants
n=107 Participants
14 participants
n=206 Participants
33 participants
n=157 Participants

PRIMARY outcome

Timeframe: 6 months

Blood pressure Control at 6 months

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Blood Pressure Control
BP controlled
0.646 proportion of participants
0.543 proportion of participants
0.458 proportion of participants
Blood Pressure Control
BP not controlled
0.354 proportion of participants
0.457 proportion of participants
0.542 proportion of participants

PRIMARY outcome

Timeframe: 6 months

Mean systolic Blood Pressure

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Systolic Blood Pressure
131.2 mm Hg
Interval 129.1 to 133.3
131.8 mm Hg
Interval 129.9 to 133.7
134.7 mm Hg
Interval 132.7 to 136.7

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Change in Proportion With BP Under Control From Baseline to 6 Months
.197 Proportion of participants
.118 Proportion of participants
.019 Proportion of participants

SECONDARY outcome

Timeframe: Baseline and 6 months

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Change in Systolic Blood Pressure From Baseline to 6 Months
-4.7 mm Hg
Interval -6.9 to -2.5
-5.4 mm Hg
Interval -8.5 to -2.3
-2.7 mm Hg
Interval -5.0 to -0.4

SECONDARY outcome

Timeframe: baseline and 6 months

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Change in Number of Cardio Exercise Hours From Baseline to 6 Months
-0.29 hours
Interval -1.7 to 1.1
0.53 hours
Interval -0.6 to 1.7
-0.43 hours
Interval -1.4 to 0.6

SECONDARY outcome

Timeframe: baseline and 6 months

Morkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4. A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Change in Morisky Score From Baseline to 6 Months
0.25 units on a scale
Interval 0.1 to 0.4
0.25 units on a scale
Interval 0.1 to 0.4
0.14 units on a scale
Interval 0.0 to 0.3

SECONDARY outcome

Timeframe: 6 months

The stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Diet Stage of Change
Action or Maintenance
87 participants
73 participants
73 participants
Diet Stage of Change
Precontemplation, Contemplation or Preparation
69 participants
86 participants
97 participants

SECONDARY outcome

Timeframe: 6 months

The stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Exercise Stage of Change
Action or Maintenance
128 participants
124 participants
126 participants
Exercise Stage of Change
Precontemplation, Contemplation or Preparation
28 participants
35 participants
44 participants

SECONDARY outcome

Timeframe: 6 months

The stages of change were: precontemplation, or no plans to adhere in \<6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for \<6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.

Outcome measures

Outcome measures
Measure
Stage-matched Intervention (SMI)
n=156 Participants
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=159 Participants
6 monthly calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=170 Participants
treatment as usual for hypertension
Medication Stage of Change
Action or Maintenance
148 participants
156 participants
163 participants
Medication Stage of Change
Precontemplation, Contemplation or Preparation
8 participants
3 participants
7 participants

Adverse Events

Stage-matched Intervention (SMI)

Serious events: 3 serious events
Other events: 14 other events
Deaths: 0 deaths

Health Education Intervention (HEI)

Serious events: 1 serious events
Other events: 7 other events
Deaths: 0 deaths

Usual Care (UC)

Serious events: 3 serious events
Other events: 9 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Stage-matched Intervention (SMI)
n=176 participants at risk
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=177 participants at risk
6 monthly phone calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=180 participants at risk
treatment as usual for hypertension
Cardiac disorders
Heart attack
1.1%
2/176 • Number of events 2 • 1 year
0.00%
0/177 • 1 year
0.56%
1/180 • Number of events 1 • 1 year
Vascular disorders
Stroke
0.00%
0/176 • 1 year
0.00%
0/177 • 1 year
1.1%
2/180 • Number of events 2 • 1 year
General disorders
Death
0.57%
1/176 • Number of events 1 • 1 year
0.56%
1/177 • Number of events 1 • 1 year
0.00%
0/180 • 1 year

Other adverse events

Other adverse events
Measure
Stage-matched Intervention (SMI)
n=176 participants at risk
6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model
Health Education Intervention (HEI)
n=177 participants at risk
6 monthly phone calls of nontailored counseling for diet, medication and exercise
Usual Care (UC)
n=180 participants at risk
treatment as usual for hypertension
Cardiac disorders
Angina
2.8%
5/176 • Number of events 5 • 1 year
1.7%
3/177 • Number of events 3 • 1 year
2.2%
4/180 • Number of events 4 • 1 year
Injury, poisoning and procedural complications
broken bones
2.8%
5/176 • Number of events 5 • 1 year
0.56%
1/177 • Number of events 1 • 1 year
0.56%
1/180 • Number of events 1 • 1 year
Musculoskeletal and connective tissue disorders
torn ligament
1.1%
2/176 • Number of events 2 • 1 year
0.00%
0/177 • 1 year
1.1%
2/180 • Number of events 2 • 1 year
Cardiac disorders
hypertensive emergency
0.00%
0/176 • 1 year
0.56%
1/177 • Number of events 1 • 1 year
1.1%
2/180 • Number of events 2 • 1 year
Surgical and medical procedures
Coronary artery bypass graft
1.1%
2/176 • Number of events 2 • 1 year
1.1%
2/177 • Number of events 2 • 1 year
0.00%
0/180 • 1 year

Additional Information

Sundar Natarajan, MD, Staff Physician

Department of Veterans Affairs

Phone: 212-686-7500

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place